Lihong Wang

Title: Lihong Wang: Innovator in Antibody Development

Introduction

Lihong Wang is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 9 patents to his name, Wang's work has the potential to impact therapeutic treatments significantly.

Latest Patents

Wang's latest patents include highly potent antibodies binding to death receptor 5 and death receptor 4. The first patent focuses on monoclonal antibodies that bind to these receptors, along with a pharmaceutical composition comprising the antibodies. This invention also outlines methods of treatment that involve administering the pharmaceutical composition to patients. The second patent similarly addresses monoclonal antibodies binding to death receptor 4 and/or death receptor 5, emphasizing their therapeutic applications.

Career Highlights

Throughout his career, Lihong Wang has worked with notable companies such as Galaxy Biotech, LLC and Novartis AG. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Wang has collaborated with several talented individuals in his field, including Kyung Jin Kim and Hangil Park. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Lihong Wang's contributions to the field of biotechnology, particularly in monoclonal antibody development, showcase his innovative spirit and dedication to improving therapeutic treatments. His work continues to pave the way for advancements in medical science.